Johnson & Johnson
J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance
Syringes and a box of Johnson & Johnson vaccine. Paul Hennessy | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and stopped providing Covid-19 vaccine revenue guidance due to a global supply surplus and demand uncertainty. J&J is now forecasting 2022 sales of $94.8 […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures fall as the 10-year Treasury yield tops a 3-year high Traders on the floor of the NYSE, April 14, 2022. Source: NYSE 2. BofA issues stronger earnings as it releases reserves for soured loans A […]
Read More
Cramer’s week ahead: Keep an eye on bonds and Ukraine as earnings season picks up
CNBC’s Jim Cramer on Thursday previewed next week’s slate of earnings and what investors should have on their radar to prepare for the tumultuous market ahead. The “Mad Money” host said that bonds, Russia’s invasion of Ukraine and Covid lockdowns in China are “the stories that do matter with treasurys running roughshod over everything once […]
Read More
Stocks could stay choppy as fears about the Fed overshadow earnings news
Traders on the floor of the NYSE, March 29, 2022. Source: NYSE Earnings season is here, and it may distract investors from other issues, but it’s not likely to be the big driver of the overall market in the week ahead. Investors instead will keep an eye on the things that have been worrying the […]
Read More
Next decade will transform health care more than past century: Johnson & Johnson CEO
Andrew Harrer | Bloomberg | Getty Images Joaquin Duato, the new CEO of Johnson & Johnson, is comfortable enough in his new position at the 135-year-old company to issue a bold claim just a few months into the job and during his first interview: he predicts the next decade will see more health-care transformation than […]
Read More
5 things to know before the stock market opens Wednesday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street looks lower after logging a multiday winning streak Traders on the floor of the NYSE, March 29, 2022. Source: NYSE U.S. stock futures pointed to a lower open Wednesday, one day after the Dow Jones […]
Read More
Buy Teva Pharmaceuticals amid confluence of positive news, Bernstein says
A recent bout of good news makes Teva Pharmaceuticals a good buy for investors, even though the company faces ongoing opioid litigation, according to Bernstein. Source
Read More
Vaccine maker stocks rise as China battles worst Covid outbreak since 2020
Shares of the major vaccine makers rose on Monday as China battles its worst Covid outbreak since 2020, fueling fear that the pandemic will drag on which could drive demand for future vaccine orders. Moderna‘s stock jumped more than 8% to close at $150.07. In the morning, the biotech company’s stock had surged nearly 20% […]
Read More
Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants
Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. “I think we’re going to submit to FDA a significant progress of data about the need for a fourth […]
Read More